Latest period
$458.00M
YoY change
+69.6%
5Y CAGR
+9.5%
Peak year (2025)
$468.90M
Latest annual
$468.90M
Free Cash Flow history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: $468.90M
Free Cash Flow growth chart for West Pharmaceutical Services (WST) from 1989 to 2025
Latest: +69.6%
Free Cash Flow history table for West Pharmaceutical Services (WST) from 1989 to 2025
| 2025 | $468.90M | +69.6% | +$192.50M | ||
| 2024 | $276.40M | -33.3% | −$138.10M | ||
| 2023 | $414.50M | -5.7% | −$24.90M | ||
| 2022 | $439.40M | +32.9% | +$108.80M | ||
| 2021 | $330.60M | +10.9% | +$32.50M | ||
| 2020 | $298.10M | +23.8% | +$57.30M | ||
| 2019 | $240.80M | +30.9% | +$56.90M | ||
| 2018 | $183.90M | +38.8% | +$51.40M | ||
| 2017 | $132.50M | +169.3% | +$83.30M | ||
| 2016 | $49.20M | -39.1% | −$31.60M | ||
| 2015 | $80.80M | +14.1% | +$10.00M | ||
| 2014 | $70.80M | +9.4% | +$6.10M | ||
| 2013 | $64.70M | +16.8% | +$9.30M | ||
| 2012 | $55.40M | +63.4% | +$21.50M | ||
| 2011 | $33.90M | -47.4% | −$30.60M | ||
| 2010 | $64.50M | +115.7% | +$34.60M | ||
| 2009 | $29.90M | -829.3% | +$34.00M | ||
| 2008 | −$4.10M | +1950.0% | −$3.90M | ||
| 2007 | −$200.00K | -100.4% | −$53.70M | ||
| 2006 | $53.50M | +69.8% | +$22.00M | ||
| 2005 | $31.50M | +173.9% | +$20.00M | ||
| 2004 | $11.50M | +36.9% | +$3.10M | ||
| 2003 | $8.40M | -48.1% | −$7.80M | ||
| 2002 | $16.20M | -242.1% | +$27.60M | ||
| 2001 | −$11.40M | +31.0% | −$2.70M | ||
| 2000 | −$8.70M | -245.0% | −$14.70M | ||
| 1999 | $6.00M | -205.3% | +$11.70M | ||
| 1998 | −$5.70M | -117.1% | −$39.00M | ||
| 1997 | $33.30M | +5.0% | +$1.60M | ||
| 1996 | $31.70M | +114.2% | +$16.90M | ||
| 1995 | $14.80M | -34.8% | −$7.90M | ||
| 1994 | $22.70M | +354.0% | +$17.70M | ||
| 1993 | $5.00M | -56.9% | −$6.60M | ||
| 1992 | $11.60M | -38.6% | −$7.30M | ||
| 1991 | $18.90M | +575.0% | +$16.10M | ||
| 1990 | $2.80M | -67.4% | −$5.80M | ||
| 1989 | $8.60M | — | — |
- 2025$468.90M+69.6%
- 2024$276.40M-33.3%
- 2023$414.50M-5.7%
- 2022$439.40M+32.9%
- 2021$330.60M+10.9%
- 2020$298.10M+23.8%
- 2019$240.80M+30.9%
- 2018$183.90M+38.8%
- 2017$132.50M+169.3%
- 2016$49.20M-39.1%
- 2015$80.80M+14.1%
- 2014$70.80M+9.4%
- 2013$64.70M+16.8%
- 2012$55.40M+63.4%
- 2011$33.90M-47.4%
- 2010$64.50M+115.7%
- 2009$29.90M-829.3%
- 2008−$4.10M+1950.0%
- 2007−$200.00K-100.4%
- 2006$53.50M+69.8%
- 2005$31.50M+173.9%
- 2004$11.50M+36.9%
- 2003$8.40M-48.1%
- 2002$16.20M-242.1%
- 2001−$11.40M+31.0%
- 2000−$8.70M-245.0%
- 1999$6.00M-205.3%
- 1998−$5.70M-117.1%
- 1997$33.30M+5.0%
- 1996$31.70M+114.2%
- 1995$14.80M-34.8%
- 1994$22.70M+354.0%
- 1993$5.00M-56.9%
- 1992$11.60M-38.6%
- 1991$18.90M+575.0%
- 1990$2.80M-67.4%
- 1989$8.60M—
Free Cash Flow values are taken from West Pharmaceutical Services's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at West Pharmaceutical Services (WST)
Free Cash Flow for West Pharmaceutical Services (WST): headline value $458.00M · YoY +69.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
West Pharmaceutical Services (WST) most recent annual free cash flow stands at $468.90M (2025) – surged 69.6% year-over-year.
West Pharmaceutical Services free cash flow has grown on net over the period, with a +9.5% compound annual growth rate over 2020–2025 (5 years).
Across the available history, free cash flow reached its high of $468.90M in 2025 and its low of −$11.40M in 2001.
West Pharmaceutical Services Free Cash Flow by Year
West Pharmaceutical Services Free Cash Flow 2025: $468.90M
West Pharmaceutical Services posted free cash flow of $468.90M in 2025, surged 69.6% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Free Cash Flow 2024: $276.40M
In 2024, West Pharmaceutical Services reported free cash flow of $276.40M, plunged 33.3% below 2023.
West Pharmaceutical Services Free Cash Flow 2023: $414.50M
West Pharmaceutical Services free cash flow in 2023 was $414.50M, declined 5.7% below 2022.
West Pharmaceutical Services Free Cash Flow 2022: $439.40M
2022's free cash flow for West Pharmaceutical Services came in at $439.40M, surged 32.9% from 2021.
West Pharmaceutical Services Free Cash Flow 2021: $330.60M
West Pharmaceutical Services free cash flow in 2021 was $330.60M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Free Cash Flow
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation